Patent details

EP4125896 Title: TREATMENT OF TYPE 2 DIABETES WITH 2-[(4-{6-[(4-CYANO-2-FLUOROBENZYL)OXY]PYRIDIN-2-YL} PIPERIDIN-1-YL)METHYL]-1-[(2S)-OXETAN-2-YLMETHYL]-1H-BENZIMIDAZOLE-6-CARBOXYLIC ACID OR A PHARMACEUTICALLY SALT THEREOF

Basic Information

Publication number:
EP4125896
PCT Application Number:
IB2021052430
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP217146851
PCT Publication Number:
WO2021191812
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
TREATMENT OF TYPE 2 DIABETES WITH 2-[(4-{6-[(4-CYANO-2-FLUOROBENZYL)OXY]PYRIDIN-2-YL} PIPERIDIN-1-YL)METHYL]-1-[(2S)-OXETAN-2-YLMETHYL]-1H-BENZIMIDAZOLE-6-CARBOXYLIC ACID OR A PHARMACEUTICALLY SALT THEREOF
French Title of Invention:
TRAITEMENT DU DIABÈTE DE TYPE 2 AVEC DE L'ACIDE 2-[(4-{6-[(4-CYANO-2-FLUOROBENZYL) OXY]PYRIDIN-2-YL}PIPÉRIDIN-1-YL)MÉTHYL]-1-[(2S)-OXÉTAN-2-YLMÉTHYL]-1H-BENZIMIDAZOLE-6-CARBOXYLIQUE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE CORRESPONDANT
German Title of Invention:
BEHANDLUNG VON TYP 2 DIABETES MIT 2-[(4{6-((4-CYANO-2-FLUORBENZYL)OXY)PYRIDIN-2-YL}PIPERIDIN-1-YL)METHYL!-1-[(2S)-OXETAN-2-YLMETHYL)-1H-BENZIMIDAZOL-6-CARBONSÄURE ODER EINEM PHARMAZEUTISCHEN SALZ DAVON
SPC Number:

Dates

Filing date:
24/03/2021
Grant date:
07/05/2025
EP Publication Date:
08/02/2023
PCT Publication Date:
30/09/2021
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
07/05/2025
EP B1 Publication Date:
07/05/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
24/03/2041
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
30/04/2025
 
 

Name:
Pfizer Inc.
Address:
66 Hudson Boulevard East, New York, NY 10001-2192, United States (US)

Inventor

1

Name:
MANTHENA, Sweta
Address:
United States (US)

2

Name:
LEE, Kai Teck
Address:
United Kingdom (GB)

3

Name:
SAXENA, Aditi Rao
Address:
United States (US)

Priority

1

Priority Number:
202063000787 P
Priority Date:
27/03/2020
Priority Country:
United States (US)

2

Priority Number:
202063126113 P
Priority Date:
16/12/2020
Priority Country:
United States (US)

3

Priority Number:
202163135870 P
Priority Date:
11/01/2021
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/4545; A61P 3/04; A61P 3/10; A61K 9/20;

Publication

European Patent Bulletin

Issue number:
202519
Publication date:
07/05/2025
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
30/09/2026
Annual Fee Number:
6
Annual Fee Amount:
66 Euro
Penalty Fee Amount:
20 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages